Medicare Enrolled

Dr. David Goldberg, M.D

MOHS-Micrographic Surgery Physician · Hackensack, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Research-focused
20 PROSPECT AVE STE 702, Hackensack, NJ 07601
9083598980
In practice since 2006 (20 years)
NPI: 1528001583 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goldberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldberg? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goldberg

Dr. David Goldberg is a mohs-micrographic surgery physician in Hackensack, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goldberg performed 1,612 Medicare services across 1,048 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goldberg received a total of $1,013,371 from 48 pharmaceutical and/or device companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goldberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,612 Medicare services $1,013,371 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,612
Medicare services
Bottom 26% in NJ for mohs-micrographic surgery physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,048
Unique beneficiaries
$141
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
364 $71 $195
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
337 $6 $50
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
134 $78 $349
Skin growth removal and lab exam, 1-5 blocks
This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory.
111 $479 $1,613
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
90 $49 $296
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
89 $77 $250
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $42 $150
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks 76 $366 $632
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
74 $46 $173
Skin growth removal and lab exam, 1-5 blocks
A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination.
45 $556 $863
Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm
A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length.
33 $235 $1,686
Skin graft repair, 10 sq cm or less
A surgical procedure to repair a wound by transferring a small piece of skin to the affected area. The graft covers wounds on the face, neck, hands, feet, or other specified body parts.
28 $652 $1,257
Skin graft repair of eyelid, nose, ear, or lip, 10 sq cm or less
A surgical procedure to repair a wound on the eyelid, nose, ear, or lip by transferring a small piece of skin. The transferred skin covers an area of 10 square centimeters or less.
25 $664 $2,088
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
25 $129 $375
Complicated wound repair of trunk, 2.6-7.5 cm
A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length.
21 $222 $914
Complicated wound repair, 2.6-7.5 cm
A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet.
20 $284 $850
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
20 $54 $225
Additional Mohs surgery stage with microscopic exam
This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth.
18 $356 $642
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
15 $95 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
13.8% medium
85.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,013,371
Total received (2018-2024)
Avg $144,767/year across 7 years
Top 0% in NJ for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
327
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$582,634 (57.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$263,886 (26.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$162,296 (16.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,555 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$171,197
2023
$219,433
2022
$18,830
2021
$39,408
2020
$88,166
2019
$195,558
2018
$280,778

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$142,009
Musculoskeletal Transplant Foundation Inc.
$10,500
Biofrontera Inc.
$10,500
Verrica Pharmaceuticals Inc.
$7,750
REVANCE THERAPEUTICS, INC.
$103
SUN PHARMACEUTICAL INDUSTRIES INC.
$91
E.R. Squibb & Sons, L.L.C.
$62
ConvaTec Inc.
$60
Amgen Inc.
$31
GENZYME CORPORATION
$22
Fidia Pharma USA Inc.
$20
Lilly USA, LLC
$17
Arcutis Biotherapeutics, Inc.
$16
Incyte Corporation
$16
Top 3 companies account for 95.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$330,897
Galderma Laboratories, L.P.
$254,355
Sensus Healthcare, Inc.
$157,257
Lumenis, Inc
$84,217
Musculoskeletal Transplant Foundation Inc.
$74,591
Allergan Inc.
$17,146
Ra Medical Systems, Inc.
$15,116
Biofrontera Inc.
$12,113
Regeneron Pharmaceuticals, Inc.
$10,250
GENZYME CORPORATION
$9,484
Verrica Pharmaceuticals Inc.
$7,767
Allergan, Inc.
$7,382
MERZ NORTH AMERICA, INC.
$5,196
Regeneron Healthcare Solutions, Inc.
$3,925
Ipsen Innovation
$3,515
Almirall LLC
$3,266
MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC.
$3,100
DERMIRA, INC.
$2,986
Solta Medical, a division of Bausch Health US, LLC
$2,610
EPI Health, LLC
$1,677
Aclaris Therapeutics, Inc.
$1,500
Merz North America, Inc.
$1,431
Incyte Corporation
$1,078
MITSUBISHI TANABE PHARMA AMERICA, INC.
$700
Organogenesis Inc.
$323
E.R. Squibb & Sons, L.L.C.
$200
Novartis Pharmaceuticals Corporation
$144
Endo Pharmaceuticals Inc.
$136
REVANCE THERAPEUTICS, INC.
$103
ORGANOGENESIS INC.
$98
PFIZER INC.
$98
Lilly USA, LLC
$95
Sun Pharmaceutical Industries Inc.
$94
SUN PHARMACEUTICAL INDUSTRIES INC.
$91
ConvaTec Inc.
$83
LEO Pharma Inc.
$66
VYNE Pharmaceuticals Inc.
$56
NOBELPHARMA AMERICA, LLC
$37
Amgen Inc.
$31
Smith & Nephew, Inc.
$28
Fidia Pharma USA Inc.
$20
Kerecis Limited
$18
Arcutis Biotherapeutics, Inc.
$16
Taro Pharmaceuticals USA, Inc.
$15
Kyowa Kirin, Inc.
$15
Genentech USA, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Ortho Dermatologics, a division of Bausch Health US, LLC
$12
Top 3 companies account for 73.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · AMZEEQ · Absorica LD · Ameluz · BF-RhodoLED · BOTOX · BOTOX COSMETIC · CLODERM · COSENTYX · DAXXIFY · DERMATITIS - DISEASE · DUPIXENT · DYSPORT · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Erivedge · FINACEA · HALOG (Halcinonide Cream · HYFTOR · INNOVAMATRIX AC · Kerecis Omega3 Wound · Klisyri · LIBTAYO · NO PRODUCT DISCUSSED · OLUMIANT · OPZELURA · ORACEA · Otezla · PHAROS laser system · POTELIGEO · Puraply · QBREXZA · RHOFADE · SEYSARA · SILIQ · SKYRIZI · SOOLANTRA · Santyl · Seysara · Sotyktu · TALTZ · USP) 0.1% · Veltin · WYNZORA · Winlevi · XEOMIN · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 0% for mohs-micrographic surgery physician in NJ.

Looking for a mohs-micrographic surgery physician in Hackensack?
Compare mohs-micrographic surgery physicians in the Hackensack area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

Mohs-micrographic surgery physicians within 10 mi
39
Per 100K population
4.1
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goldberg is a clinical cardiology specialist, with moderate Medicare volume, with research-focused industry engagement in the top 0% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Goldberg experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Goldberg performed 364 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldberg receive payments from pharmaceutical companies?
Yes. Dr. Goldberg received a total of $1,013,371 from 48 companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldberg's costs compare to other mohs-micrographic surgery physicians in Hackensack?
Dr. Goldberg's average Medicare payment per service is $141. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →